Cevimeline hydrochloride
Code | Size | Price |
---|
TAR-T20131-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T20131-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Cevimeline HCl is an agonist of cholinergic that binds to muscarinic receptors. Muscarinic agonists in sufficient dosage can enhance the secretion of exocrine glands, such as salivary and sweat glands.
CAS:
107220-28-0
Formula:
C10H18ClNOS
Molecular Weight:
235.77
Purity:
0.98
SMILES:
Cl.C[C@@H]1O[C@@]2(CS1)CN1CCC2CC1
References
1. Malallah OS, Garcia CMA, Proctor GB, Forbes B, Royall PG. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth). Int J Pharm. 2018 Apr 25;541(1-2):157-166. doi: 10.1016/j.ijpharm.2018.02.004. Epub 2018 Feb 6. Review. PubMed PMID: 29425763.
2. Togashi H, Matsumoto M, Yoshioka M, Saito Y, Saito H. Effects of a novel cholinergic M1 agonist, AF102B, on ambulation and water drinking behavior in rats. Hokkaido Igaku Zasshi. 1991 Jan;66(1):59-66. PubMed PMID: 2004736.